Sort by
Refine Your Search
-
PhD studentship: Teaching Intelligent Agents to See, Think and Act with Vision and Language Award Summary 100% fees covered, and a minimum tax-free annual living allowance of £20,780 (2025/26 UKRI
-
Award Summary 100% fees covered, and a minimum tax-free annual living allowance of £20,780 (2025/26 UKRI rate). Additional project costs will also be provided. Overview How can we revolutionise intelligent systems that still rely on fixed rules and structured commands? For example, if asked to...
-
that will train the next-generation of doctoral carbon champions who are renowned for research excellence and interdisciplinary systemic thinking for Net Zero. The ReNU+ vision is that they will become
-
following possible projects: Bionic Vision microelectronics: In this project, you would develop advanced low-power mixed-signal (analog + digital) circuitry on CMOS chips which will drive our custom implants
-
motivated, creative, and curious PhD candidate excited to bridge disciplines and co-develop this research. You will join a collaborative and internationally active Regenerative Engineering Group, with scope
-
industrial practice relies heavily on empirical optimisation, leading to inefficiencies in energy use and impurity removal. This PhD project proposes to develop a Coupled Computational Fluid Dynamics-Discrete
-
allowance of £20,780 (2025/26 UKRI rate). Additional project costs will also be provided. Overview This PhD will develop a Synovium-on-a-Chip, using 3D bioprinting, microfluidic engineering, and computational
-
-grade experience that employers value. The journey You'll develop machine-readable privacy rules, build core functionalities that audit and explain data-sharing decisions, prototype agent systems showing
-
, what changes are made (e.g., labelling), and how it is used (e.g., which models train on it, which versions, for what purpose). Middleware solutions: In this topic, we will explore middleware solutions
-
Overview The project aims to develop a new approach to drug discovery by developing new methods for synthesising and testing potential drug candidates in high-throughput. One of the barriers